Cipla to Acquire 21.85% Stake in GoApptiv for ~$1.2M

 Cipla to Acquire 21.85% Stake in GoApptiv for ~$1.2M

Shots:

  • Cipla to acquire 21.85% stake in GoApptiv on a fully diluted basis for ~1.2M (₹9 crores) which included ₹5.80 crores in the first stage and ₹3.20 crores in the second stage. The acquisition will expand the reach of Cipla’s brand in tier three-plus towns
  • In the first stage, a subscription of 15,392 compulsorily convertible preference shares and purchase of 6,927 equity shares are expected to be closed within 30 days from the execution date while in the second stage, a subscription of 12,314 compulsorily convertible preference shares is expected to close by Oct 31, 2020
  • GoApptiv offers digital solutions for integrated brand sales management, digital marketing, and channel engagement for pharmaceutical companies and provides digital solutions for customer relationship management, patient support, and healthcare data analytics

Click here to read full press release/ article | Ref: Cipla | Image: ET Healthworld

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post